Tumor microenvironment: a prospective target of natural alkaloids for cancer treatment

1.

Zaorsky N, Churilla T, Egleston B, Fisher S, Ridge J, Horwitz E, et al. Causes of death among cancer patients. Ann Oncol. 2016. https://doi.org/10.1093/annonc/mdw604.CrossRefPubMedCentral

2.

Huang C, Wang X-l, Qi F-f, Pang Z-l. Berberine inhibits epithelial-mesenchymal transition and promotes apoptosis of tumour-associated fibroblast-induced colonic epithelial cells through regulation of TGF-β signalling. J Cell Commun Signal. 2019;14(1):53–66. https://doi.org/10.1007/s12079-019-00525-7.CrossRefPubMedPubMedCentral

3.

Afsharimani B, Baran J, Watanabe S, Lindner D, Cabot PJ, Parat M-O. Morphine and breast tumor metastasis: the role of matrix-degrading enzymes. Clin Exp Metas. 2013;31(2):149–58. https://doi.org/10.1007/s10585-013-9616-3.CrossRef

4.

Kozlova N, Grossman JE, Iwanicki MP, Muranen T. The interplay of the extracellular matrix and stromal cells as a drug target in stroma-rich cancers. Trends Pharmacol Sci. 2020;41(3):183–98. https://doi.org/10.1016/j.tips.2020.01.001.CrossRefPubMedPubMedCentral

5.

Mitra AK, Agrahari V, Mandal A, Cholkar K, Natarajan C, Shah S, Joseph M, Trinh HM, Vaishya R, Yang X, Hao Y, Khurana V, Pal D. Novel delivery approaches for cancer therapeutics. J Control Release. 2015;219:248–68. https://doi.org/10.1016/j.jconrel.2015.09.067.CrossRefPubMedPubMedCentral

6.

D’Arcangelo E, Wu NC, Cadavid JL, McGuigan AP. The life cycle of cancer-associated fibroblasts within the tumour stroma and its importance in disease outcome. Br J Cancer. 2020;122(7):931–42. https://doi.org/10.1038/s41416-019-0705-1.CrossRefPubMedPubMedCentral

7.

Rossi GR, Trindade ES, Souza-Fonseca-Guimaraes F. Tumor microenvironment-associated extracellular matrix components regulate NK cell function. Front Immunol. 2020. https://doi.org/10.3389/fimmu.2020.00073.CrossRefPubMedPubMedCentral

8.

Gaziano R. Antitumor effects of the benzophenanthridine alkaloid sanguinarine: evidence and perspectives. World J Gastroint Oncol. 2016. https://doi.org/10.4251/wjgo.v8.i1.30.CrossRef

9.

Wang Y, Ma S, Ruzzo WL. Spatial modeling of prostate cancer metabolic gene expression reveals extensive heterogeneity and selective vulnerabilities. Sci Rep. 2020. https://doi.org/10.1038/s41598-020-60384-w.CrossRefPubMedPubMedCentral

10.

Laplane L, Duluc D, Bikfalvi A, Larmonier N, Pradeu T. Beyond the tumour microenvironment. Int J Cancer. 2019;145(10):2611–8. https://doi.org/10.1002/ijc.32343.CrossRefPubMedPubMedCentral

11.

He J, Yin P, Xu K. Effect and molecular mechanisms of traditional Chinese medicine on tumor targeting tumor-associated macrophages. Drug Des Dev Ther. 2020;14:907–19. https://doi.org/10.2147/dddt.S223646.CrossRef

12.

Li X, Yu N, Li J, Bai J, Ding D, Tang Q, Xu H. Novel “Carrier-Free” Nanofiber Codelivery Systems with the Synergistic Antitumor Effect of Paclitaxel and Tetrandrine through the Enhancement of Mitochondrial Apoptosis. ACS Appl Mater Interfaces. 2020;12(9):10096–106. https://doi.org/10.1021/acsami.9b17363.CrossRefPubMed

13.

Xu P, Jiang Y, Zuo H, Liu X, Xia T, Zhou R, Chen B, Ouyang J. Vincristine-loaded platelets coated with anti-CD41 mAbs: a new macrophage targeting proposal for the treatment of immune thrombocytopenia. Biomater Sci. 2019;7(11):4568–77. https://doi.org/10.1039/c9bm01026b.CrossRefPubMed

14.

Laskar P, Somani S, Campbell SJ, Mullin M, Keating P, Tate RJ, Irving C, Leung HY, Dufès C. Camptothecin-based dendrimersomes for gene delivery and redox-responsive drug delivery to cancer cells. Nanoscale. 2019;11(42):20058–71. https://doi.org/10.1039/c9nr07254c.CrossRefPubMed

15.

Ren H, Zhao J, Fan D, Wang Z, Zhao T, Li Y, Zhao Y, Adelson D, Hao H. Alkaloids from nux vomica suppresses colon cancer cell growth through Wnt/β-catenin signaling pathway. Phytother Res. 2019;33(5):1570–8. https://doi.org/10.1002/ptr.6347.CrossRefPubMed

16.

Ndongo JT, Mbing JN, Tala MF, Monteillier A, Pegnyemb DE, Cuendet M, Laatsch H. Indoline alkaloids from Tabernaemontana contorta with cancer chemopreventive activity. Phytochemistry. 2017;144:189–96. https://doi.org/10.1016/j.phytochem.2017.09.013.CrossRefPubMed

17.

Tang W, Yang J, Yuan Y, Zhao Z, Lian Z, Liang G. Paclitaxel nanoparticle awakens immune system to fight against cancer. Nanoscale. 2017. https://doi.org/10.1039/c6nr09895a.CrossRefPubMedPubMedCentral

18.

Fan S, Cao YX, Li GY, Lei H, Zhang SQ. F10, a new camptothecin derivative, was identified as a new orally-bioavailable, potent antitumor agent. Eur J Med Chem. 2020;202:112528.CrossRefPubMed

19.

Kim SY, Hwangbo H, Lee H, Park C, Kim G-Y, Moon S-K, Yun SJ, Kim W-J, Cheong J, Choi YH. Induction of apoptosis by coptisine in Hep3B hepatocellular carcinoma cells through activation of the ROS-mediated JNK signaling pathway. Int J Mol Sci. 2020. https://doi.org/10.3390/ijms21155502.CrossRefPubMedPubMedCentral

20.

Avtanski DB, Nagalingam A, Tomaszewski JE, Risbood P, Difillippantonio MJ, Saxena NK, Malhotra SV, Sharma D. Indolo-pyrido-isoquinolin based alkaloid inhibits growth, invasion and migration of breast cancer cells via activation of p53-miR34a axis. Mol Oncol. 2016;10(7):1118–32. https://doi.org/10.1016/j.molonc.2016.04.003.CrossRefPubMedPubMedCentral

21.

Li X, Ma H, Li L, Chen Y, Sun X, Dong Z, Liu JY, Zhu W, Zhang JT. Novel synthetic bisindolylmaleimide alkaloids inhibit STAT3 activation by binding to the SH2 domain and suppress breast xenograft tumor growth. Oncogene. 2018;37(18):2469–80. https://doi.org/10.1038/s41388-017-0076-0.CrossRefPubMedPubMedCentral

22.

Parsonage G, Filer AD, Haworth O, Nash GB, Rainger GE, Salmon M, Buckley CD. A stromal address code defined by fibroblasts. Trends Immunol. 2005;26(3):150–6. https://doi.org/10.1016/j.it.2004.11.014.CrossRefPubMedPubMedCentral

23.

Errarte P, Larrinaga G, Lopez JI. The role of cancer-associated fibroblasts in renal cell carcinoma. An example of tumor modulation through tumor/non-tumor cell interactions. J Adv Res. 2020;21:103–8. https://doi.org/10.1016/j.jare.2019.09.004.CrossRefPubMed

24.

Houthuijzen JM, Jonkers J. Cancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment. Cancer Metastasis Rev. 2018;37(4):577–97. https://doi.org/10.1007/s10555-018-9768-3.CrossRefPubMed

25.

Xiang H, Ramil CP, Hai J, Zhang C, Wang H, Watkins AA, Afshar R, Georgiev P, Sze MA, Song XS, Curran PJ, Cheng M, Miller JR, Sun D, Loboda A, Jia Y, Moy LY, Chi A, Brandish PE. Cancer-associated fibroblasts promote immunosuppression by inducing ROS-generating monocytic MDSCs in lung squamous cell carcinoma. Cancer Immunol Res. 2020;8(4):436–50. https://doi.org/10.1158/2326-6066.CIR-19-0507.CrossRefPubMed

26.

Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16(9):582–98. https://doi.org/10.1038/nrc.2016.73.CrossRefPubMed

27.

Kim E, Kim W, Lee S, Chun J, Kang J, Park G, Han I, Yang HJ, Youn H, Youn B. TRAF4 promotes lung cancer aggressiveness by modulating tumor microenvironment in normal fibroblasts. Sci Rep. 2017;7(1):8923. https://doi.org/10.1038/s41598-017-09447-z.CrossRefPubMedPubMedCentral

28.

Kato T, Noma K, Ohara T, Kashima H, Katsura Y, Sato H, Komoto S, Katsube R, Ninomiya T, Tazawa H, Shirakawa Y, Fujiwara T. Cancer-associated fibroblasts affect intratumoral CD8(+) and FoxP3(+) T cells via IL6 in the tumor microenvironment. Clin Cancer Res. 2018;24(19):4820–33. https://doi.org/10.1158/1078-0432.CCR-18-0205.CrossRefPubMed

29.

Chen PC, Lee WY, Ling HH, Cheng CH, Chen KC, Lin CW. Activation of fibroblasts by nicotine promotes the epithelial-mesenchymal transition and motility of breast cancer cells. J Cell Physiol. 2018;233(6):4972–80. https://doi.org/10.1002/jcp.26334.CrossRefPubMed

30.

Ishii N, Araki K, Yokobori T, Hagiwara K, Gantumur D, Yamanaka T, Handa T, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Harimoto N, Masamune A, Umezawa K, Kuwano H, Shirabe K. Conophylline suppresses pancreatic cancer desmoplasia and cancer-promoting cytokines produced by cancer-associated fibroblasts. Cancer Sci. 2019;110(1):334–44. https://doi.org/10.1111/cas.13847.CrossRefPubMed

31.

Zhu Y, Yang J, Xu D, Gao XM, Zhang Z, Hsu JL, Li CW, Lim SO, Sheng YY, Zhang Y, Li JH, Luo Q, Zheng Y, Zhao Y, Lu L, Jia HL, Hung MC, Dong QZ, Qin LX. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade. Gut. 2019;68(9):1653–66. https://doi.org/10.1136/gutjnl-2019-318419.CrossRefPubMed

32.

Antropow AH, Xu K, Buchsbaum RJ, Movassaghi M. Synthesis and evaluation of agelastatin derivatives as potent modulators for cancer invasion and metastasis. J Org Chem. 2017;82(15):7720–31. https://doi.org/10.1021/acs.joc.7b01162.CrossRefPubMedPubMedCentral

33.

Xu K, Tian X, Oh SY, Movassaghi M, Naber SP, Kuperwasser C, Buchsbaum RJ. The fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis. Breast Cancer Res. 2016. https://doi.org/10.1186/s13058-016-0674-8.CrossRefPubMedPubMedCentral

34.

Watad A, Rowe H, Russell T, Zhou Q, Anderson LK, Khan A, Dunsmuir R, Loughenbury P, Borse V, Rao A, Millner PA, Bragazzi NL, Amital H, Cuhtbert R, Wittmann M, Sharif K, Kenna T, Brown MA, Newton D, Bridgewood C, McGonagle DG. Normal human enthesis harbours conventional CD4+ and CD8+ T cells with regulatory features and inducible IL-17A and TNF expression. Ann Rheum Dis. 2020;79(8):1044–54. https://doi.org/10.1136/annrheumdis-2020-217309.CrossRefPubMed

35.

Lee H, Kim YA, Kim Y, Park HS, Seo JH, Lee H, Gong G, Lee HJ. Clinicopathological factors associated with tumor-infiltrating lymphocyte reactivity in breast cancer. Cancer Immunol Immunother. 2020. https://doi.org/10.1007/s00262-020-02633-5.CrossRefPubMedPubMedCentral

36.

Kim W, Khan SK, Liu Y, Xu R, Park O, He Y, Cha B, Gao B, Yang Y. Hepatic Hippo signaling inhibits protumoural microenvironment to suppress hepatocellular carcinoma. Gut. 2018;67(9):1692–703. https://doi.org/10.1136/gutjnl-2017-314061.CrossRefPubMed

37.

Quan H, Shan Z, Liu Z, Liu S, Yang L, Fang X, Li K, Wang B, Deng Z, Hu Y, Yao Z, Huang J, Yu J, Xia K, Tang Z, Fang L. The repertoire of tumor-infiltrating lymphocytes within the microenvironment of oral squamous cell carcinoma reveals immune dysfunction. Cancer Immunol Immunother. 2020;69(3):465–76. https://doi.org/10.1007/s00262-020-02479-x.CrossRefPubMed

38.

Li T, Wu B, Yang T, Zhang L, Jin K. The outstanding antitumor capacity of CD4(+) T helper lymphocytes. Biochimica Biophysica Acta Rev Cancer. 2020. https://doi.org/10.1016/j.bbcan.2020.188439.CrossRef

39.

Li X, Wang B, Li Y, Wang L, Zhao X, Zhou X, Guo Y, Jiang G, Yao C. The Th1/Th2/Th17/Treg paradigm induced by stachydrine hydrochloride reduces uterine bleeding in RU486-induced abortion mice. J Ethnopharmacol. 2013;145(1):241–53. https://doi.org/10.1016/j.jep.2012.10.059.CrossRefPubMed

40.

Lind H, Gameiro SR, Jochems C, Donahue RN, Strauss J, Gulley JM, Palena C, Schlom J. Dual targeting of TGF-beta and PD-L1 via a bifunctional anti-PD-L1/TGF-betaRII agent: status of preclinical and clinical advances. J Immunother Cancer. 2020. https://doi.org/10.1136/jitc-2019-000433.CrossRefPubMedPubMedCentral

41.

Ge X, Zhao Y, Chen C, Wang J, Sun L. Cancer immunotherapies targeting tumor-associated regulatory T cells. Onco Targets Ther. 2019;12:11033–44. https://doi.org/10.2147/OTT.S231052.CrossRefPubMedPubMedCentral

42.

Tian S, Miao M, Bai M, Yanyi Wu, Gao J, Guo L. Effect of stachydrine hydrochloride to the prostate hyperplasia model in mice. Saudi J Biol Sci. 2019;26(4):782–9. https://doi.org/10.1016/j.sjbs.2018.12.012.CrossRefPubMed

43.

Zhao L, Wu D, Sang M, Xu Y, Liu Z, Wu Q. Stachydrine ameliorates isoproterenol-induced cardiac hypertrophy and fibrosis by suppressing inflammation and oxidative stress through inhibiting NF-kappaB and JAK/STAT signaling pathways in rats. Int Immunopharmacol. 2017;48:102–9. https://doi.org/10.1016/j.intimp.2017.05.002.CrossRefPubMed

44.

Li S, Huang C, Hu G, Ma J, Chen Y, Zhang J, Huang Y, Zheng J, Xue W, Xu Y, Zhai W. Tumor-educated B cells promote renal cancer metastasis via inducing the IL-1β/HIF-2α/Notch1 signals. Cell Death Dis. 2020;11(3):163. https://doi.org/10.1038/s41419-020-2355-x.CrossRefPubMedPubMedCentral

45.

Suryawanshi A, Hussein MS, Prasad PD, Manicassamy S. Wnt signaling cascade in dendritic cells and regulation of anti-tumor immunity. Front Immunol. 2020;11:122. https://doi.org/10.3389/fimmu.2020.00122.CrossRefPubMedPubMedCentral

46.

Poropatich K, Dominguez D, Chan WC, Andrade J, Zha Y, Wray B, Miska J, Qin L, Cole L, Coates S, Patel U, Samant S, Zhang B. OX40+ plasmacytoid dendritic cells in the tumor microenvironment promote antitumor immunity. J Clin Invest. 2020;130(7):3528–42. https://doi.org/10.1172/JCI131992.CrossRefPubMedPubMedCentral

47.

Liu H, Zou M, Li P, Wang H, Lin X, Ye J. Oxymatrinemediated maturation of dendritic cells leads to activation of FOXP3+/CD4+ Treg cells and reversal of cisplatinresistance in lung cancer cells. Mol Med Rep. 2019;19(5):4081–90. https://doi.org/10.3892/mmr.2019.10064.CrossRefPubMedPubMedCentral

48.

Weng TY, Wu HF, Li CY, Hung YH, Chang YW, Chen YL, Hsu HP, Chen YH, Wang CY, Chang JY, Lai MD. Homoharringtonine induced immune alteration for an efficient anti-tumor response in mouse models of non-small cell lung adenocarcinoma expressing Kras mutation. Sci Rep. 2018;8(1):8216. https://doi.org/10.1038/s41598-018-26454-w.CrossRefPubMedPubMedCentral

49.

Cao W, Liu Y, Zhang R, Zhang B, Wang T, Zhu X, Mei L, Chen H, Zhang H, Ming P, Huang L. Homoharringtonine induces apoptosis and inhibits STAT3 via IL-6/JAK1/STAT3 signal pathway in Gefitinib-resistant lung cancer cells. Sci Rep. 2015;5:8477. https://doi.org/10.1038/srep08477.CrossRefPubMedPubMedCentral

50.

Tan M, Zhang Q, Yuan X, Chen Y, Wu Y. Synergistic killing effects of homoharringtonine and arsenic trioxide on acute myeloid leukemia stem cells and the underlying mechanisms. J Exp Clin Cancer Res. 2019;38(1):308. https://doi.org/10.1186/s13046-019-1295-8.CrossRefPubMedPubMedCentral

51.

Chen XJ, Zhang WN, Chen B, Xi WD, Lu Y, Huang JY, Wang YY, Long J, Wu SF, Zhang YX, Wang S, Li SX, Yin T, Lu M, Xi XD, Li JM, Wang KK, Chen Z, Chen SJ. Homoharringtonine deregulates MYC transcriptional expression by directly binding NF-kappaB repressing factor. Proc Natl Acad Sci USA. 2019;116(6):2220–5. https://doi.org/10.1073/pnas.1818539116.CrossRefPubMedPubMedCentral

52.

Hock BD, MacPherson SA, McKenzie JL. Idelalisib and caffeine reduce suppression of T cell responses mediated by activated chronic lymphocytic leukemia cells. PLoS One. 2017;12(3):e0172858. https://doi.org/10.1371/journal.pone.0172858.CrossRefPubMedPubMedCentral

53.

Guo G, Shi F, Zhu J, Shao Y, Gong W, Zhou G, Wu H, She J, Shi W. Piperine, a functional food alkaloid, exhibits inhibitory potential against TNBS-induced colitis via the inhibition of I-kappaB-alpha/NF-kappaB and induces tight junction protein (claudin-1, occludin, and ZO-1) signaling pathway in experimental mice. Hum Exp Toxicol. 2020;39(4):477–91. https://doi.org/10.1177/0960327119892042.CrossRefPubMed

54.

Choi DW, Jung SY, Shon DH, Shin HS. Piperine Ameliorates Trimellitic anhydride-induced atopic dermatitis-like symptoms by suppressing Th2-mediated immune responses via inhibition of STAT6 phosphorylation. Molecules. 2020. https://doi.org/10.3390/molecules25092186.CrossRefPubMedPubMedCentral

55.

Gillen KM, Mubarak M, Nguyen TD, Pitt D. Significance and in vivo detection of iron-laden microglia in white matter multiple sclerosis lesions. Front Immunol. 2018;9:255. https://doi.org/10.3389/fimmu.2018.00255.CrossRefPubMedPubMedCentral

56.

Bravo-Flores E, Mancilla-Herrera I, Espino YSS, Ortiz-Ramirez M, Flores-Rueda V, Ibarguengoitia-Ochoa F, Ibanez CA, Zambrano E, Solis-Paredes M, Perichart-Perera O, Sanchez-Martinez M, Medina-Bastidas D, Reyes-Munoz E, Estrada-Gutierrez G. Macrophage populations in visceral adipose tissue from pregnant women: potential role of obesity in maternal inflammation. Int J Mol Sci. 2018. https://doi.org/10.3390/ijms19041074.CrossRefPubMedPubMedCentral

57.

Ma W, Zhao D, He F, Tang L. The role of kupffer cells as mediators of adipose tissue lipolysis. J Immunol. 2019;203(10):2689–700. https://doi.org/10.4049/jimmunol.1900366.CrossRefPubMed

58.

Wang PL, Yim AKY, Kim KW, Avey D, Czepielewski RS, Colonna M, Milbrandt J, Randolph GJ. Peripheral nerve resident macrophages share tissue-specific programming and features of activated microglia. Nat Commun. 2020;11(1):2552. https://doi.org/10.1038/s41467-020-16355-w.CrossRefPubMedPubMedCentral

59.

Dou L, Shi X, He X, Gao Y. Macrophage phenotype and function in liver disorder. Front Immunol. 2019;10:3112. https://doi.org/10.3389/fimmu.2019.03112.CrossRefPubMed

60.

Hoeffel G, Ginhoux F. Ontogeny of tissue-resident macrophages. Front Immunol. 2015;6:486. https://doi.org/10.3389/fimmu.2015.00486.CrossRefPubMedPubMedCentral

61.

Kumar S, Ramesh A, Kulkarni A. Targeting macrophages: a novel avenue for cancer drug discovery. Expert Opin Drug Discov. 2020;15(5):561–74. https://doi.org/10.1080/17460441.2020.1733525.CrossRefPubMed

62.

Noy R, Pollard Jeffrey W. Tumor-associated macrophages: from mechanisms to therapy. Immunity. 2014;41(1):49–61. https://doi.org/10.1016/j.immuni.2014.06.010.CrossRefPubMedPubMedCentral

63.

Guo Y, Feng Y, Cui X, Wang Q, Pan X. Autophagy inhibition induces the repolarisation of tumour-associated macrophages and enhances chemosensitivity of laryngeal cancer cells to cisplatin in mice. Cancer Immunol Immunother. 2019;68(12):1909–20. https://doi.org/10.1007/s00262-019-02415-8.CrossRefPubMed

64.

Sarode P, Schaefer MB, Grimminger F, Seeger W, Savai R. Macrophage and tumor cell cross-talk is fundamental for lung tumor progression: we need to talk. Front Oncol. 2020;10:324. https://doi.org/10.3389/fonc.2020.00324.CrossRefPubMedPubMedCentral

65.

Beltraminelli T, De Palma M. Biology and therapeutic targeting of tumour-associated macrophages. J Pathol. 2020;250(5):573–92. https://doi.org/10.1002/path.5403.CrossRefPubMed

66.

Cao M, Yan H, Han X, Weng L, Wei Q, Sun X, Lu W, Wei Q, Ye J, Cai X, Hu C, Yin X, Cao P. Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth. J Immunother Cancer. 2019;7(1):326. https://doi.org/10.1186/s40425-019-0817-4.CrossRefPubMedPubMedCentral

67.

Hartley GP, Chow L, Ammons DT, Wheat WH, Dow SW. Programmed cell death ligand 1 (PD-L1) signaling regulates macrophage proliferation and activation. Cancer Immunol Res. 2018;6(10):1260–73. https://doi.org/10.1158/2326-6066.CIR-17-0537.CrossRefPubMed

68.

Lee KG, Lee SG, Lee HH, Lee HJ, Shin JS, Kim NJ, An HJ, Nam JH, Jang DS, Lee KT. alpha-Chaconine isolated from a Solanum tuberosum L. cv Jayoung suppresses lipopolysaccharide-induced pro-inflammatory mediators via AP-1 inactivation in RAW 264.7 macrophages and protects mice from endotoxin shock. Chem Biol Interact. 2015;235:85–94. https://doi.org/10.1016/j.cbi.2015.04.015.CrossRefPubMed

69.

Ribeiro-Filho J, Carvalho Leite F, Surrage Calheiros A, de Brito CA, Alves Azeredo J, Fernandes de Assis E, da Silva Dias C, Regina Piuvezam M, Patricia TB. Curine inhibits macrophage activation and neutrophil recruitment in a mouse model of lipopolysaccharide-induced inflammation. Toxins. 2019. https://doi.org/10.3390/toxins11120705.CrossRefPubMedPubMedCentral

70.

Yao M, Fan X, Yuan B, Takagi N, Liu S, Han X, Ren J, Liu J. Berberine inhibits NLRP3 inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell. BMC Complement Altern Med. 2019;19(1):216. https://doi.org/10.1186/s12906-019-2615-4.CrossRefPubMedPubMedCentral

71.

Slusarczyk J, Trojan E, Glombik K, Piotrowska A, Budziszewska B, Kubera M, Popiolek-Barczyk K, Lason W, Mika J, Basta-Kaim A. Targeting the NLRP3 inflammasome-related pathways via tianeptine treatment-suppressed microglia polarization to the M1 phenotype in lipopolysaccharide-stimulated cultures. Int J Mol Sci. 2018. https://doi.org/10.3390/ijms19071965.CrossRefPubMedPubMedCentral

72.

Conos SA, Chen KW, De Nardo D, Hara H, Whitehead L, Nunez G, Masters SL, Murphy JM, Schroder K, Vaux DL, Lawlor KE, Lindqvist LM, Vince JE. Active MLKL triggers the NLRP3 inflammasome in a cell-intrinsic manner. Proc Natl Acad Sci USA. 2017;114(6):E961–9. https://doi.org/10.1073/pnas.1613305114.CrossRefPubMedPubMedCentral

73.

Zhang L, Fan Y, Su H, Wu L, Huang Y, Zhao L, Han B, Shu G, Xiang M, Yang JM. Chlorogenic acid methyl ester exerts strong anti-inflammatory effects via inhibiting the COX-2/NLRP3/NF-kappaB pathway. Food Funct. 2018;9(12):6155–64. https://doi.org/10.1039/c8fo01281d.CrossRefPubMed

74.

Zhou Y, Zhu X, Wang X, Peng Y, Du J, Yin H, Yang H, Ni X, Zhang W. H2S alleviates renal injury and fibrosis in response to unilateral ureteral obstruction by regulating macrophage infiltration via inhibition of NLRP3 signaling. Exp Cell Res. 2020;387(1): 111779. https://doi.org/10.1016/j.yexcr.2019.111779.CrossRefPubMed

75.

Xu G, Feng D, Yao Y, Li P, Sun H, Yang H, Li C, Jiang R, Sun B, Chen Y. Listeria-based hepatocellular carcinoma vaccine facilitates anti-PD-1 therapy by regulating macrophage polarization. Oncogene. 2020;39(7):1429–44. https://doi.org/10.1038/s41388-019-1072-3.CrossRefPubMed

76.

Kim HG, Han EH, Jang WS, Choi JH, Khanal T, Park BH, Tran TP, Chung YC, Jeong HG. Piperine inhibits PMA-induced cyclooxygenase-2 expression through downregulating NF-kappaB, C/EBP and AP-1 signaling pathways in murine macrophages. Food Chem Toxicol. 2012;50(7):2342–8. https://doi.org/10.1016/j.fct.2012.04.024.CrossRefPubMed

77.

Zheng Y, Yang Y, Li Y, Xu L, Wang Y, Guo Z, Song H, Yang M, Luo B, Zheng A, Li P, Zhang Y, Ji G, Yu Y. Ephedrine hydrochloride inhibits PGN-induced inflammatory responses by promoting IL-10 production and decreasing proinflammatory cytokine secretion via the PI3K/Akt/GSK3beta pathway. Cell Mol Immunol. 2013;10(4):330–7. https://doi.org/10.1038/cmi.2013.3.CrossRefPubMedPubMedCentral

78.

Zhu L, Huang S, Li J, Chen J, Yao Y, Li L, Guo H, Xiang X, Deng J, Xiong J. Sophoridine inhibits lung cancer cell growth and enhances cisplatin sensitivity through activation of the p53 and Hippo signaling pathways. Gene. 2020;742:144556. https://doi.org/10.1016/j.gene.2020.144556.CrossRefPubMed

79.

Wang W, Cai Y, Zhang G, Liu Y, Sui H, Park K, Wang H. Sophoridine-loaded PLGA microspheres for lung targeting: preparation, in vitro, and in vivo evaluation. Drug Deliv. 2016;23(9):3674–80. https://doi.org/10.1080/10717544.2016.1223210.CrossRefPubMed

80.

Zhuang H, Dai X, Zhang X, Mao Z, Huang H. Sophoridine suppresses macrophage-mediated immunosuppression through TLR4/IRF3 pathway and subsequently upregulates CD8(+) T cytotoxic function against gastric cancer. Biomed Pharmacother. 2020;121:109636. https://doi.org/10.1016/j.biopha.2019.109636.CrossRefPubMed

81.

Wang B, Xu J, Wang H, Chang S, Liu N. Effect and mechanism of sophoridine to suppress hepatocellular carcinoma in vitro and vivo. Biomed Pharmacother. 2017;95:324–30. https://doi.org/10.1016/j.biopha.2017.08.029.CrossRefPubMed

82.

Zhao WL, Xing Y, Ye C, Qiu YH, Li Y, Liu XJ, Wang MY, Bi CW, Song DQ, Shao RG. The novel quinolizidine derivate IMB-HDC inhibits STAT5a phosphorylation at 694 and 780 and promotes DNA breakage and cell apoptosis via blocking STAT5a nuclear translocation. Acta Pharmacol Sin. 2020;41(5):686–97. https://doi.org/10.1038/s41401-019-0333-6.CrossRefPubMedPubMedCentral

83.

Batra R, Suh MK, Carson JS, Dale MA, Meisinger TM, Fitzgerald M, Opperman PJ, Luo J, Pipinos II, Xiong W, Baxter BT. IL-1beta (interleukin-1beta) and TNF-alpha (tumor necrosis factor-alpha) impact abdominal aortic aneurysm formation by differential effects on macrophage polarization. Arterioscler Thromb Vasc Biol. 2018;38(2):457–63. https://doi.org/10.1161/ATVBAHA.117.310333.CrossRefPubMed

84.

Zhao L, Wang L, Di SN, Xu Q, Ren QC, Chen SZ, Huang N, Jia D, Shen XF. Steroidal alkaloid solanine A from Solanum nigrum Linn. exhibits anti-inflammatory activity in lipopolysaccharide/interferon gamma-activated murine macrophages and animal models of inflammation. Biomed Pharmacother. 2018;105:606–15. https://doi.org/10.1016/j.biopha.2018.06.019.CrossRefPubMed

85.

Zhong Y, Chen B, Feng J, Cheng L, Li Y, Qian J, Ding J, Gao F, Xia G, Chen N, Lu Z. The associations of Janus kinase-2 (JAK2) A830G polymorphism and the treatment outcomes in patients with acute myeloid leukemia. Leuk Lymphoma. 2010;51(6):1115–20. https://doi.org/10.3109/10428191003774960.CrossRefPubMed

86.

Li Z, Li H, Zhao ZB, Zhu W, Feng PP, Zhu XW, Gong JP. SIRT4 silencing in tumor-associated macrophages promotes HCC development via PPARdelta signalling-mediated alternative activation of macrophages. J Exp Clin Cancer Res. 2019;38(1):469. https://doi.org/10.1186/s13046-019-1456-9.CrossRefPubMedPubMedCentral

87.

Kim HS, Asmis R. Mitogen-activated protein kinase phosphatase 1 (MKP-1) in macrophage biology and cardiovascular disease. A redox-regulated master controller of monocyte function and macrophage phenotype. Free Radic Biol Med. 2017;109:75–83. https://doi.org/10.1016/j.freeradbiomed.2017.03.020.CrossRefPubMedPubMedCentral

88.

Pang L, Liu CY, Gong GH, Quan ZS. Synthesis, in vitro and in vivo biological evaluation of novel lappaconitine derivatives as potential anti-inflammatory agents. Acta Pharm Sin B. 2020;10(4):628–45. https://doi.org/10.1016/j.apsb.2019.09.002.CrossRefPubMed

89.

Meng Y, Qu Y, Wu W, Chen L, Sun L, Tai G, Zhou Y, Cheng H. Galactan isolated from Cantharellus cibarius modulates antitumor immune response by converting tumor-associated macrophages toward M1-like phenotype. Carbohydr Polym. 2019;226:115295. https://doi.org/10.1016/j.carbpol.2019.115295.CrossRefPubMed

90.

Wanderley CW, Colon DF, Luiz JPM, Oliveira FF, Viacava PR, Leite CA, Pereira JA, Silva CM, Silva CR, Silva RL, Speck-Hernandez CA, Mota JM, Alves-Filho JC, Lima-Junior RC, Cunha TM, Cunha FQ. Paclitaxel reduces tumor growth by reprogramming tumor-associated macrophages to an M1 profile in a TLR4-dependent manner. Cancer Res. 2018;78(20):5891–900. https://doi.org/10.1158/0008-5472.CAN-17-3480.CrossRefPubMed

91.

Nishina T, Boku N, Gotoh M, Shimada Y, Hamamoto Y, Yasui H, et al. Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing regimen. Gastric Cancer. 2016;19(3):902–10. https://doi.org/10.1007/s10120-015-0542-8.CrossRefPubMed

92.

Münz F, Perez RL, Trinh T, Sisombath S, Nicolay NH. Human mesenchymal stem cells lose their functional properties after paclitaxel treatment. Sci Rep. 2018;8(1):312. https://doi.org/10.1038/s41598-017-18862-1.CrossRefPubMedPubMedCentral

93.

Li R, Zi M-J, Gou Z-P, Zhao Y-L, et al. Pharmacokinetics and safety evaluation in healthy Chinese volunteers of alkaloids from leaf of Alstonia scholaris: a multiple doses phase I clinical trial. Phytomedicine. 2019;61:152828. https://doi.org/10.1016/j.phymed.2019.152828.CrossRefPubMed

94.

Hass R. Role of MSC in the tumor microenvironment. Cancers. 2020. https://doi.org/10.3390/cancers12082107.CrossRefPubMedPubMedCentral

95.

Munz F, Lopez Perez R, Trinh T, Sisombath S, Weber KJ, Wuchter P, Debus J, Saffrich R, Huber PE, Nicolay NH. Human mesenchymal stem cells lose their functional properties after paclitaxel treatment. Sci Rep. 2018;8(1):312. https://doi.org/10.1038/s41598-017-18862-1.CrossRefPubMedPubMedCentral

96.

Keshavarz M, Ebrahimzadeh MS, Miri SM, Dianat-Moghadam H, Ghorbanhosseini SS, Mohebbi SR, Keyvani H, Ghaemi A. Oncolytic Newcastle disease virus delivered by Mesenchymal stem cells-engineered system enhances the therapeutic effects altering tumor microenvironment. Virol J. 2020. https://doi.org/10.1186/s12985-020-01326-w.CrossRefPubMedPubMedCentral

97.

Wang X, Gao J, Ouyang X, Wang J, Sun X, Lv Y. Mesenchymal stem cells loaded with paclitaxel-poly(lactic-co-glycolic acid) nanoparticles for glioma-targeting therapy. Int J Nanomedicine. 2018;13:5231–48. https://doi.org/10.2147/IJN.S167142.CrossRefPubMedPubMedCentral

98.

Marofi F, Vahedi G, Biglari A, Esmaeilzadeh A, Athari SS. Mesenchymal stromal/stem cells: a new era in the cell-based targeted gene therapy of cancer. Front Immunol. 2017;8:1770. https://doi.org/10.3389/fimmu.2017.01770.CrossRefPubMedPubMedCentral

99.

Zhang TY, Huang B, Wu HB, Wu JH, Li LM, Li YX, Hu YL, Han M, Shen YQ, Tabata Y, Gao JQ. Synergistic effects of co-administration of suicide gene expressing mesenchymal stem cells and prodrug-encapsulated liposome on aggressive lung melanoma metastases in mice. J Control Release. 2015;209:260–71. https://doi.org/10.1016/j.jconrel.2015.05.007.CrossRefPubMed

100.

Liu Y, Ren H, Zhou Y, Shang L, Zhang Y, Yang F, Shi X. The hypoxia conditioned mesenchymal stem cells promote hepatocellular carcinoma progression through YAP mediated lipogenesis reprogramming. J Exp Clin Cancer Res. 2019;38(1):228. https://doi.org/10.1186/s13046-019-1219-7.CrossRefPubMedPubMedCentral

101.

Li H, Guo L, Jie S, Liu W, Zhu J, Du W, Fan L, Wang X, Fu B, Huang S. Berberine inhibits SDF-1-induced AML cells and leukemic stem cells migration via regulation of SDF-1 level in bone marrow stromal cells. Biomed Pharmacother. 2008;62(9):573–8. https://doi.org/10.1016/j.biopha.2008.08.003.CrossRefPubMed

102.

Calvani M, Bruno G, Dabraio A, Subbiani A, Bianchini F, Fontani F, Casazza G, Vignoli M, De Logu F, Frenos S, Filippi L, Favre C. β3-Adrenoreceptor blockade induces stem cells differentiation in melanoma microenvironment. Int J Mol Sci. 2020. https://doi.org/10.3390/ijms21041420.CrossRefPubMedPubMedCentral

103.

Ahmed N, Escalona R, Leung D, Chan E, Kannourakis G. Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells. Semin Cancer Biol. 2018;53:265–81. https://doi.org/10.1016/j.semcancer.2018.10.002.CrossRefPubMed

104.

Wu HJ, Chu PY. Role of cancer stem cells in cholangiocarcinoma and therapeutic implications. Int J Mol Sci. 2019. https://doi.org/10.3390/ijms20174154.CrossRefPubMedPubMedCentral

105.

Huang T, Song X, Xu D, Tiek D, Goenka A, Wu B, Sastry N, Hu B, Cheng SY. Stem cell programs in cancer initiation, progression, and therapy resistance. Theranostics. 2020;10(19):8721–43. https://doi.org/10.7150/thno.41648.CrossRefPubMedPubMedCentral

106.

Najafi M, Mortezaee K, Majidpoor J. Cancer stem cell (CSC) resistance drivers. Life Sci. 2019;234: 116781. https://doi.org/10.1016/j.lfs.2019.116781.CrossRefPubMed

107.

Thankamony AP, Saxena K, Murali R, Jolly MK, Nair R. Cancer stem cell plasticity—a deadly deal. Front Mol Biosci. 2020;7:79. https://doi.org/10.3389/fmolb.2020.00079.CrossRefPubMedPubMedCentral

108.

Li M, Shi F, Fei X, Wu S, Wu D, Pan M, Luo S, Gu N, Dou J. PEGylated long-circulating liposomes deliver homoharringtonine to suppress multiple myeloma cancer stem cells. Exp Biol Med. 2017;242(9):996–1004. https://doi.org/10.1177/1535370216685008.CrossRef

109.

Liu Y, Qi Y, Bai ZH, Ni CX, Ren QH, Xu WH, Xu J, Hu HG, Qiu L, Li JZ, He ZG, Zhang JP. A novel matrine derivate inhibits differentiated human hepatoma cells and hepatic cancer stem-like cells by suppressing PI3K/AKT signaling pathways. Acta Pharmacol Sin. 2017;38(1):120–32. https://doi.org/10.1038/aps.2016.104.CrossRefPubMed

110.

Chen W, Wang H, Cheng M, Ni L, Zou L, Yang Q, Cai X, Jiao B. Isoharringtonine inhibits breast cancer stem-like properties and STAT3 signaling. Biomed Pharmacother. 2018;103:435–42. https://doi.org/10.1016/j.biopha.2018.04.076.CrossRefPubMed

111.

El-Merahbi R, Liu YN, Eid A, Daoud G, Hosry L, Monzer A, Mouhieddine TH, Hamade A, Najjar F, Abou-Kheir W. Berberis libanotica Ehrenb extract shows anti-neoplastic effects on prostate cancer stem/progenitor cells. PLoS One. 2014;9(11):e112453. https://doi.org/10.1371/journal.pone.0112453.CrossRefPubMedPubMedCentral

112.

Ma X, Zhou J, Zhang CX, Li XY, Li N, Ju RJ, Shi JF, Sun MG, Zhao WY, Mu LM, Yan Y, Lu WL. Modulation of drug-resistant membrane and apoptosis proteins of breast cancer stem cells by targeting berberine liposomes. Biomaterials. 2013;34(18):4452–65. https://doi.org/10.1016/j.biomaterials.2013.02.066.CrossRefPubMed

113.

Yekula A, Yekula A, Muralidharan K, Kang K, Carter BS, Balaj L. Extracellular vesicles in glioblastoma tumor microenvironment. Front Immunol. 2019;10:3137. https://doi.org/10.3389/fimmu.2019.03137.CrossRefPubMed

114.

Gieryng A, Pszczolkowska D, Walentynowicz KA, Rajan WD, Kaminska B. Immune microenvironment of gliomas. Lab Invest. 2017;97(5):498–518. https://doi.org/10.1038/labinvest.2017.19.CrossRefPubMed

115.

Yao M, Ventura PB, Jiang Y, Rodriguez FJ, Wang L, Perry JSA, Yang Y, Wahl K, Crittenden RB, Bennett ML, Qi L, Gong CC, Li XN, Barres BA, Bender TP, Ravichandran KS, Janes KA, Eberhart CG, Zong H. Astrocytic trans-differentiation completes a multicellular paracrine feedback loop required for medulloblastoma tumor growth. Cell. 2020;180(3):502-520 e519. https://doi.org/10.1016/j.cell.2019.12.024.CrossRefPubMedPubMedCentral

116.

Jacobs VL, Landry RP, Liu Y, Romero-Sandoval EA, De Leo JA. Propentofylline decreases tumor growth in a rodent model of glioblastoma multiforme by a direct mechanism on microglia. Neuro Oncol. 2012;14(2):119–31. https://doi.org/10.1093/neuonc/nor194.CrossRefPubMed

117.

Zhang H, Zhou Y, Cui B, Liu Z, Shen H. Novel insights into astrocyte-mediated signaling of proliferation, invasion and tumor immune microenvironment in glioblastoma. Biomed Pharmacother. 2020;126: 110086. https://doi.org/10.1016/j.biopha.2020.110086.CrossRefPubMed

118.

Jacobs VL, De Leo JA. Increased glutamate uptake in astrocytes via propentofylline results in increased tumor cell apoptosis using the CNS-1 glioma model. J Neurooncol. 2013;114(1):33–42. https://doi.org/10.1007/s11060-013-1158-7.CrossRefPubMedPubMedCentral

119.

Liu Y, Wei S, Zou Q, Luo Y. Stachydrine suppresses viability & migration of astrocytoma cells via CXCR4/ERK & CXCR4/Akt pathway activity. Future Oncol. 2018. https://doi.org/10.2217/fon-2017-0562.CrossRefPubMed

120.

Zhang J, Yang A, Wu Y, Guan W, Xiong B, Peng X, Wei X, Chen C, Liu Z. Stachydrine ameliorates carbon tetrachloride-induced hepatic fibrosis by inhibiting inflammation, oxidative stress and regulating MMPs/TIMPs system in rats. Biomed Pharmacother. 2018;97:1586–94. https://doi.org/10.1016/j.biopha.2017.11.117.CrossRefPubMed

121.

Chakravarthy D, Muñoz AR, Su A, Hwang RF, Keppler BR, Chan DE, Halff G, Ghosh R, Kumar AP. Palmatine suppresses glutamine-mediated interaction between pancreatic cancer and stellate cells through simultaneous inhibition of survivin and COL1A1. Cancer Lett. 2018;419:103–15. https://doi.org/10.1016/j.canlet.2018.01.057.CrossRefPubMedPubMedCentral

122.

Viallard C, Larrivée B. Tumor angiogenesis and vascular normalization: alternative therapeutic targets. Angiogenesis. 2017;20(4):409–26. https://doi.org/10.1007/s10456-017-9562-9.CrossRefPubMed

123.

Li S, Xu HX, Wu CT, Wang WQ, Jin W, Gao HL, Li H, Zhang SR, Xu JZ, Qi ZHJA. Angiogenesis in pancreatic cancer: current research status and clinical implications. Angiogenesis. 2019;22(1):15–36.CrossRefPubMed

124.

Wen Z, Huang C, Xu Y, Xiao Y, Tang L, Dai J, Sun H, Chen B, Zhou M. α-Solanine inhibits vascular endothelial growth factor expression by down-regulating the ERK1/2-HIF-1α and STAT3 signaling pathways. Eur J Pharmacol. 2016;771:93–8. https://doi.org/10.1016/j.ejphar.2015.12.020.CrossRefPubMed

125.

Nie X, Dai Y, Tan J, Chen Y, Qin G, Mao W, Zou J, Chang Y, Wang Q, Chen J. α-Solanine reverses pulmonary vascular remodeling and vascular angiogenesis in experimental pulmonary artery hypertension. J Hypertens. 2017;35(12):2419–35. https://doi.org/10.1097/hjh.0000000000001475.CrossRefPubMed

126.

Shin J-S, Lee K-G, Lee H-H, Lee HJ, An H-J, Nam J-H, Jang DS, Lee K-T. α-Solanine isolated from Solanum Tuberosum L. cv Jayoung Abrogates LPS-induced inflammatory responses Via NF-κB inactivation in RAW 264.7 macrophages and endotoxin-induced shock model in mice. J Cell Biochem. 2016;117(10):2327–39. https://doi.org/10.1002/jcb.25530.CrossRefPubMed

127.

Jie S, Li H, Tian Y, Guo D, Zhu J, Gao S, Jiang L. Berberine inhibits angiogenic potential of Hep G2 cell line through VEGF down-regulation in vitro. J Gastroenterol Hepatol. 2011;26(1):179–85. https://doi.org/10.1111/j.1440-1746.2010.06389.x.CrossRefPubMed

128.

Zhang H, Ren Y, Tang X, Wang K, Liu Y, Zhang L, Li X, Liu P, Zhao C, He J. Vascular normalization induced by sinomenine hydrochloride results in suppressed mammary tumor growth and metastasis. Sci Rep. 2015. https://doi.org/10.1038/srep08888.CrossRefPubMedPubMedCentral

129.

Li C, Cai G, Song D, Gao R, Teng P, Zhou L, Ji Q, Sui H, Cai J, Li Q, Wang Y. Development of EGFR-targeted evodiamine nanoparticles for the treatment of colorectal cancer. Biomater Sci. 2019;7(9):3627–39. https://doi.org/10.1039/c9bm00613c.CrossRefPubMed

130.

Huang JUN, Chen Z-H, Ren C-M, Wang D-X, Yuan S-X, Wu Q-X, Chen Q-Z, Zeng Y-H, Shao Y, Li Y, Wu KE, Yu YU, Sun W-J, He B-C. Antiproliferation effect of evodiamine in human colon cancer cells is associated with IGF-1/HIF-1α downregulation. Oncol Rep. 2015;34(6):3203–11. https://doi.org/10.3892/or.2015.4309.CrossRefPubMed

131.

Guo X-X, Li X-P, Zhou P, Li D-Y, Lyu X-T, Chen Y, Lyu Y-W, Tian K, Yuan D-Z, Ran J-H, Chen D-L, Jiang R, Li J. Evodiamine induces apoptosis in SMMC-7721 and HepG2 cells by suppressing NOD1 signal pathway. Int J Mol Sci. 2018. https://doi.org/10.3390/ijms19113419.CrossRefPubMedPubMedCentral

132.

Bräutigam J, Bischoff I, Schürmann C, Buchmann G, Epah J, Fuchs S, Heiss E, Brandes RP, Fürst R. Narciclasine inhibits angiogenic processes by activation of Rho kinase and by downregulation of the VEGF receptor 2. J Mol Cell Cardiol. 2019;135:97–108. https://doi.org/10.1016/j.yjmcc.2019.08.001.CrossRefPubMed

133.

Huelsken J, Hanahan D. A subset of cancer-associated fibroblasts determines therapy resistance. Cell. 2018;172(4):643–4. https://doi.org/10.1016/j.cell.2018.01.028.CrossRefPubMed

134.

Deng G, Zeng S, Ma J, Zhang Y, Qu Y, Han Y, Yin L, Cai C, Guo C, Shen H. The anti-tumor activities of Neferine on cell invasion and oxaliplatin sensitivity regulated by EMT via Snail signaling in hepatocellular carcinoma. Sci Rep. 2017. https://doi.org/10.1038/srep41616.CrossRefPubMedPubMedCentral

135.

Achkar IW, Mraiche F, Mohammad RM, Uddin S. Anticancer potential of sanguinarine for various human malignancies. Future Med Chem. 2017;9(9):933–50.CrossRefPubMed

136.

Su Q, Fan M, Wang J, Ullah A, Ghauri MA, Dai B, Zhan Y, Zhang D, Zhang Y. Sanguinarine inhibits epithelial–mesenchymal transition via targeting HIF-1α/TGF-β feed-forward loop in hepatocellular carcinoma. Cell Death Dis. 2019. https://doi.org/10.1038/s41419-019-2173-1.CrossRefPubMedPubMedCentral

137.

Jiang Y, Jiao Y, Liu Y, Zhang M, Wang Z, Li Y, Li T, Zhao X, Wang D. Sinomenine hydrochloride inhibits the metastasis of human glioblastoma cells by suppressing the expression of matrix metalloproteinase-2/-9 and reversing the endogenous and exogenous epithelial-mesenchymal transition. Int J Mol Sci. 2018. https://doi.org/10.3390/ijms19030844.CrossRefPubMedPubMedCentral

138.

Weng Y-S, Tseng H-Y, Chen Y-A, Shen P-C, Al Haq AT, Chen L-M, Tung Y-C, Hsu H-L. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer. Mol Cancer. 2019. https://doi.org/10.1186/s12943-019-0988-0.CrossRefPubMedPubMedCentral

139.

Kim S, Lee J, You D, Jeong Y, Jeon M, Yu J, Kim Seok W, Nam Seok J, Lee Jeong E. Berberine suppresses cell motility through downregulation of TGF-β1 in triple negative breast cancer cells. Cell Physiol Biochem. 2018;45(2):795–807. https://doi.org/10.1159/000487171.CrossRefPubMed

140.

Kahata K, Dadras MS, Moustakas A. TGF-β family signaling in epithelial differentiation and epithelial–mesenchymal transition. Cold Spring Harb Perspect Biol. 2018. https://doi.org/10.1101/cshperspect.a022194.CrossRefPubMedPubMedCentral

141.

Juarez P, Mohammad KS, Yin JJ, Fournier PG, McKenna RC, Davis HW, Peng XH, Niewolna M, Javelaud D, Chirgwin JM, Mauviel A, Guise TA. Halofuginone inhibits the establishment and progression of melanoma bone metastases. Cancer Res. 2012;72(23):6247–56. https://doi.org/10.1158/0008-5472.CAN-12-1444.CrossRefPubMedPubMedCentral

142.

Song L, Wang Y, Zhen Y, Li D, He X, Yang H, Zhang H, Liu Q. Piperine inhibits colorectal cancer migration and invasion by regulating STAT3/Snail-mediated epithelial-mesenchymal transition. Biotechnol Lett. 2020;42(10):2049–58. https://doi.org/10.1007/s10529-020-02923-z.CrossRefPubMed

143.

Li R, Zi M-J, Gou Z-P, et al. Pharmacokinetics and safety evaluation in healthy Chinese volunteers of alkaloids from leaf of Alstonia scholaris: a multiple doses phase I clinical trial. Phytomedicine. 2019;61–152828:0944–7113. https://doi.org/10.1016/j.phymed.2019.152828.CrossRef

144.

Northcott JM, Northey JJ, Barnes JM, Weaver VM. Fighting the force: potential of homeobox genes for tumor microenvironment regulation. Biochim Biophys Acta. 2015;1855(2):248–53. https://doi.org/10.1016/j.bbcan.2015.03.004.CrossRefPubMedPubMedCentral

145.

Johan MZ, Samuel MS. Rho–ROCK signaling regulates tumor-microenvironment interactions. Biochem Soc Trans. 2019;47(1):101–8. https://doi.org/10.1042/bst20180334.CrossRefPubMed

146.

Kim JH, Cho EB, Lee J, Jung O, Ryu BJ, Kim SH, Cho JY, Ryou C, Lee SY. Emetine inhibits migration and invasion of human non-small-cell lung cancer cells via regulation of ERK and p38 signaling pathways. Chem Biol Interact. 2015;242:25–33. https://doi.org/10.1016/j.cbi.2015.08.014.CrossRefPubMed

147.

Valadão A, Abreu C, Dias J, Arantes P, Verli H, Tanuri A, de Aguiar R. Natural plant alkaloid (Emetine) inhibits HIV-1 replication by interfering with reverse transcriptase activity. Molecules. 2015;20(6):11474–89. https://doi.org/10.3390/molecules200611474.CrossRefPubMedCentral

148.

Daneshmandi S, Wegiel B, Seth P. Blockade of lactate dehydrogenase-A (LDH-A) improves efficacy of anti-programmed cell death-1 (PD-1) therapy in melanoma. Cancers. 2019. https://doi.org/10.3390/cancers11040450.CrossRefPubMedPubMedCentral

149.

Liao Z, Chua D, Tan NS. Reactive oxygen species: a volatile driver of field cancerization and metastasis. Mol Cancer. 2019. https://doi.org/10.1186/s12943-019-0961-y.CrossRefPubMedPubMedCentral

150.

Simoes ICM, Morciano G, Lebiedzinska-Arciszewska M, Aguiari G, Pinton P, Potes Y, Wieckowski MR. The mystery of mitochondria-ER contact sites in physiology and pathology: a cancer perspective. Biochimica Biophys Acta Mol Basis Dis. 2020. https://doi.org/10.1016/j.bbadis.2020.165834.CrossRef

151.

Helfinger V, Schröder K. Redox control in cancer development and progression. Mol Aspects Med. 2018;63:88–98. https://doi.org/10.1016/j.mam.2018.02.003.CrossRefPubMed

152.

Kong H, Chandel NS. Regulation of redox balance in cancer and T cells. J Biol Chem. 2018;293(20):7499–507. https://doi.org/10.1074/jbc.TM117.000257.CrossRefPubMed

153.

Frisch J, Angenendt A, Hoth M, Prates Roma L, Lis A. STIM-Orai channels and reactive oxygen species in the tumor microenvironment. Cancers. 2019. https://doi.org/10.3390/cancers11040457.CrossRefPubMedPubMedCentral

154.

Weinberg F, Ramnath N, Nagrath D. Reactive oxygen species in the tumor microenvironment: an overview. Cancers. 2019. https://doi.org/10.3390/cancers11081191.CrossRefPubMedPubMedCentral

155.

Wang P, Liang C, Zhu J, Yang N, Jiao A, Wang W, Song X, Dong X. Manganese-based nanoplatform as metal ion-enhanced ros generator for combined chemodynamic/photodynamic therapy. ACS Appl Mater Interfaces. 2019;11(44):41140–7. https://doi.org/10.1021/acsami.9b16617.CrossRefPubMed

156.

Assi M. The differential role of reactive oxygen species in early and late stages of cancer. Am J Physiol Regul Integr Comp Physiol. 2017;313(6):R646–53. https://doi.org/10.1152/ajpregu.00247.2017.CrossRefPubMed

157.

Hayes JD, Dinkova-Kostova AT, Tew KD. Oxidative stress in cancer. Cancer Cell. 2020;38(2):167–97. https://doi.org/10.1016/j.ccell.2020.06.001.CrossRefPubMedPubMedCentral

158.

Chen Q, Chen G, Chen J, Shen J, Zhang X, Wang J, Chan A, Gu Z. Bioresponsive protein complex of aPD1 and aCD47 antibodies for enhanced immunotherapy. Nano Lett. 2019;19(8):4879–89. https://doi.org/10.1021/acs.nanolett.9b00584.CrossRefPubMed

159.

Yuan Z, Liang Z, Yi J, Chen X, Li R, Wu Y, Wu J, Sun Z. Protective effect of koumine, an alkaloid from gelsemium sempervirens, on injury induced by H(2)O(2) in IPEC-J2 cells. Int J Mol Sci. 2019. https://doi.org/10.3390/ijms20030754.CrossRefPubMedPubMedCentral

160.

Yang MH, Jung SH, Sethi G, Ahn KS. Pleiotropic pharmacological actions of capsazepine, a synthetic analogue of capsaicin, against various cancers and inflammatory diseases. Molecules. 2019. https://doi.org/10.3390/molecules24050995.CrossRefPubMedPubMedCentral

161.

Xu Z, Zhang F, Bai C, Yao C, Zhong H, Zou C, Chen X. Sophoridine induces apoptosis and S phase arrest via ROS-dependent JNK and ERK activation in human pancreatic cancer cells. J Exp Clin Cancer Res. 2017;36(1):124. https://doi.org/10.1186/s13046-017-0590-5.CrossRefPubMedPubMedCentral

162.

Awale S, Dibwe DF, Balachandran C, Fayez S, Feineis D, Lombe BK, Bringmann G. Ancistrolikokine E3, a 5,8′-coupled naphthylisoquinoline alkaloid, eliminates the tolerance of cancer cells to nutrition starvation by inhibition of the Akt/mTOR/autophagy signaling pathway. J Nat Prod. 2018;81(10):2282–91. https://doi.org/10.1021/acs.jnatprod.8b00733.CrossRefPubMed

163.

Maacha S, Bhat AA, Jimenez L, Raza A, Haris M, Uddin S, et al. Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance. Mol Cancer. 2019. https://doi.org/10.1186/s12943-019-0965-7.CrossRefPubMedPubMedCentral

164.

Balaphas A, Meyer J, Sadoul R, Morel P, Bühler LH. Extracellular vesicles: future diagnostic and therapeutic tools for liver disease and regeneration. Liver Int. 2019. https://doi.org/10.1111/liv.14189.CrossRefPubMed

165.

Gu S, Song X, Xie R, Ouyang C, Xie L, Li Q, Su T, Xu M, Xu T, Huang D, Liang B, et al. Berberine inhibits cancer cells growth by suppressing fatty acid synthesis and biogenesis of extracellular vesicles. Life Sci. 2020. https://doi.org/10.1016/j.lfs.2020.118122.CrossRefPubMed

166.

Du X, Wang JN, Sun J, Wu T, Yang YK. Steroidal glycoalkaloids from solanum lyratum inhibit the pro-angiogenic activity of a549-derived exosomes. Fitoterapia. 2020;141:104481. https://doi.org/10.1016/j.fitote.2020.104481.CrossRefPubMed

167.

Lin Q, Qu M, Zhou B, Patra HK, Zhang Z. Exosome-like nanoplatform modified with targeting ligand improves anti-cancer and anti-inflammation effects of imperialine. J Control Release. 2019. https://doi.org/10.1016/j.jconrel.2019.08.037.CrossRefPubMed

168.

Anderson NM, Simon MC. The tumor microenvironment. Curr Biol. 2020;30(16):R921–5. https://doi.org/10.1016/j.cub.2020.06.081.CrossRefPubMedPubMedCentral

169.

Haider T, Sandha KK, Soni V, Gupta PN. Recent advances in tumor microenvironment associated therapeutic strategies and evaluation models. Mater Sci Eng C Mater Biol Appl. 2020;116:111229. https://doi.org/10.1016/j.msec.2020.111229.CrossRefPubMed

170.

Chandra D, Gravekamp C. Myeloid-derived suppressor cells: cellular missiles to target tumors. Oncoimmunology. 2013;2(11):e26967. https://doi.org/10.4161/onci.26967.CrossRefPubMedPubMedCentral

171.

Wilson R, Espinosa-Diez C, Kanner N, Chatterjee N, Ruhl R, Hipfinger C, Advani SJ, Li J, Khan OF, Franovic A, Weis SM, Kumar S, Coussens LM, Anderson DG, Chen CC, Cheresh DA, Anand S. MicroRNA regulation of endothelial TREX1 reprograms the tumour microenvironment. Nat Commun. 2016;7:13597. https://doi.org/10.1038/ncomms13597.CrossRefPubMedPubMedCentral

172.

Dey P, Kundu A, Chakraborty HJ, Kar B, Choi WS, Lee BM, Bhakta T, Atanasov AG, Kim HS. Therapeutic value of steroidal alkaloids in cancer: current trends and future perspectives. Int J Cancer. 2019;145(7):1731–44. https://doi.org/10.1002/ijc.31965.CrossRefPubMedPubMedCentral

173.

Havelek R, Muthna D, Tomsik P, Kralovec K, Seifrtova M, Cahlikova L, Hostalkova A, Safratova M, Perwein M, Cermakova E, Rezacova M. Anticancer potential of Amaryllidaceae alkaloids evaluated by screening with a panel of human cells, real-time cellular analysis and Ehrlich tumor-bearing mice. Chem Biol Interact. 2017;275:121–32. https://doi.org/10.1016/j.cbi.2017.07.018.CrossRefPubMed

174.

Apaza Ticona L, Arnanz Sebastian J, Serban AM, Rumbero Sanchez A. Alkaloids isolated from Tropaeolum tuberosum with cytotoxic activity and apoptotic capacity in tumour cell lines. Phytochemistry. 2020;177:112435. https://doi.org/10.1016/j.phytochem.2020.112435.CrossRefPubMed

175.

Qiao L, Han M, Gao S, Shao X, Wang X, Sun L, Fu X, Wei Q. Research progress on nanotechnology for delivery of active ingredients from traditional Chinese medicines. J Mater Chem B. 2020;8(30):6333–51. https://doi.org/10.1039/d0tb01260b.CrossRefPubMed

176.

Yang X, Liu Y, Zhao Y, Han M, Guo Y, Kuang H, et al. A stabilizer-free and organic solvent-free method to prepare 10-hydroxycamptothecin nanocrystals: in vitro and in vivo evaluation. Int J Nanomed. 2016;11:2979–94. https://doi.org/10.2147/IJN.S102726.CrossRef

177.

Hagan CT, Medik YB, Wang AZ. Nanotechnology approaches to improving cancer immunotherapy. Adv Cancer Res. 2018. https://doi.org/10.1016/bs.acr.2018.05.003.CrossRefPubMed

178.

Ledermann JA, Canevari S, Thigpen T. Targeting the folate receptor: diagnostic and therapeutic approaches to personalize cancer treatments. Ann Oncol. 2015. https://doi.org/10.1093/annonc/mdv250.CrossRefPubMed

179.

Luyckx M, Votino R, Squifflet JL, Baurain JF. Profile of vintafolide (EC145) and its use in the treatment of platinum-resistant ovarian cancer. Int J Womens Health. 2014;6:351–8. https://doi.org/10.2147/IJWH.S39696.CrossRefPubMedPubMedCentral

180.

Reddy JA, Dorton R, Bloomfield A, Nelson M, Vetzel M, Guan J, et al. Rational combination therapy of vintafolide (EC145) with commonly used chemotherapeutic drugs. Clin Cancer Res. 2014;20(8):2104–14.CrossRefPubMed

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Tumor microenvironment: a prospective target of natural alkaloids for cancer treatment

Abstract

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2021

The oncogenic role of HIF-1α/miR-182-5p/ZFP36L1 signaling pathway in nasopharyngeal carcinoma

Curcumin anti‐tumor effects on endometrial cancer with focus on its molecular targets

NCK1-AS1 promotes the progression of melanoma by accelerating cell proliferation and migration via targeting miR-526b-5p/ADAM15 axis

LncRNA CTD-3252C9.4 modulates pancreatic cancer cell survival and apoptosis through regulating IFI6 transcription

IMUP and GPRC5A: two newly identified risk score indicators in pancreatic ductal adenocarcinoma

Plastin-3 is a diagnostic and prognostic marker for pancreatic adenocarcinoma and distinguishes from diffuse large B-cell lymphoma

Keynote webinar | Spotlight on antibody–drug conjugates in cancer